Nevro (NYSE: NVRO) reported Q1 EPS of ($0.98), $0.07 better than the analyst estimate of ($1.05). Revenue for the quarter came in at $96.3 million versus the consensus estimate of $95.17 million.

GUIDANCE:

Nevro sees Q2 2023 revenue of $110-112 million, versus the consensus of $111.5 million.

Nevro sees FY2023 revenue of $445-455 million, versus the consensus of $448.9 million.

Provides Second Quarter of 2023 Non-GAAP Adjusted EBITDA Guidance of Negative $4 Million to Negative $5 Million; Reiterates Full-Year 2023 Non-GAAP Adjusted EBITDA Guidance of Negative $5 Million to Negative $10 Million

For earnings history and earnings-related data on Nevro (NVRO) click here.